Literature DB >> 18082541

The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism.

Yeşim Erbil1, Yersu Kapran, Halim Işsever, Umut Barbaros, Işik Adalet, Ferhunde Dizdaroğlu, Alp Bozbora, Selçuk Ozarmağan, Serdar Tezelman.   

Abstract

BACKGROUND: Although the sensitivity of sestamibi scanning (MIBI) is high in patients with solitary parathyroid adenomas, negative sestamibi scan results are inevitable. The exact mechanism of visualization of abnormal and hyperfunctioning parathyroid tissue is not yet clear. The aims of this clinical study were (1) to evaluate positive and negative sestamibi scan results with regard to adenoma weight and oxyphil cell content and (2) to compare the effects of adenoma weight and oxyphil cell content on the results of sestamibi scanning. PATIENTS: The patients were divided in 2 groups according to their sestamibi scan results. Group 1 consisted of 27 patients with positive sestamibi scan results, and group 2 consisted of 20 patients with negative sestamibi scan results. Parathyroid adenoma weight and oxyphil cell content were determined in all patients.
RESULTS: The weight and oxyphil cell content of the parathyroid adenomas in the patients of group 1 were significantly higher than those in the patients of group 2 (P = .001). An adenoma weight >600 mg and an oxyphil cell content >20% increased the rate of obtaining a positive sestamibi scan result 10- and 4-fold, respectively.
CONCLUSIONS: Both adenoma weight and oxyphil cell content were found to significantly correlate with positive sestamibi scan results. In patients with high-weight adenomas, adenoma weight was the most significant factor in obtaining positive MIBI scan results, whereas in patients with low adenoma weights, high oxyphil cell content was the most significant factor in obtaining positive MIBI scan results.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18082541     DOI: 10.1016/j.amjsurg.2007.01.040

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

Review 1.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

2.  Impact of thyroid nodular disease on 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism.

Authors:  Joaquin Gómez-Ramírez; Juan Jose Sancho-Insenser; Jose Antonio Pereira; Jaime Jimeno; Assumpta Munné; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2010-07-14       Impact factor: 3.445

3.  Relationship between parathyroid oxyphil cell proportion and clinical characteristics of patients with chronic kidney disease.

Authors:  Yue Ding; Qiang Zou; Yiting Jin; Jian Zhou; Hongying Wang
Journal:  Int Urol Nephrol       Date:  2019-11-04       Impact factor: 2.370

4.  Usefulness of 99mTc-SESTAMIBI Scintigraphy in Persistent Hyperparathyroidism after Kidney Transplant.

Authors:  Muheon Shin; Joon Young Choi; Sun Wook Kim; Jung Han Kim; Young Seok Cho
Journal:  Nucl Med Mol Imaging       Date:  2021-10-30

5.  Sestamibi (99mTc) scan as a single localization modality in primary hyperparathyroidism and factors impacting its accuracy.

Authors:  Yousof Alabdulkarim; Edgard Nassif
Journal:  Indian J Nucl Med       Date:  2010-01

6.  Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicenter study comprising 2,708 patients.

Authors:  Anders O J Bergenfelz; Svante K G Jansson; Göran K Wallin; Hans G Mårtensson; Lars Rasmussen; Håkan L O Eriksson; Eva I M Reihnér
Journal:  Langenbecks Arch Surg       Date:  2009-07-18       Impact factor: 3.445

Review 7.  Parathyroid nuclear scan. A focused review on the technical and biological factors affecting its outcome.

Authors:  Subramanian Kannan; Mira Milas; Donald Neumann; Rikesh T Parikh; Alan Siperstein; Angelo Licata
Journal:  Clin Cases Miner Bone Metab       Date:  2014-01

8.  Limitations of Tc99m-MIBI-SPECT imaging scans in persistent primary hyperparathyroidism.

Authors:  Janneke E Witteveen; Job Kievit; Marcel P M Stokkel; Hans Morreau; Johannes A Romijn; Neveen A T Hamdy
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

9.  SPECT/CT Fusion in the Diagnosis of Hyperparathyroidism.

Authors:  Yoshio Monzen; Akihisa Tamura; Hajime Okazaki; Taichi Kurose; Masayuki Kobayashi; Masatsugu Kuraoka
Journal:  Asia Ocean J Nucl Med Biol       Date:  2015

10.  Two cases of spontaneous remission of primary hyperparathyroidism due to auto-infarction: different management and their outcomes.

Authors:  Peter Novodvorsky; Ziad Hussein; Muhammad Fahad Arshad; Ahmed Iqbal; Malee Fernando; Alia Munir; Sabapathy P Balasubramanian
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-05-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.